Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease (Q45871425)

17 December 2017

title

Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease (English)

1 reference

17 December 2017

author name string

A Niebuhr

1

1 reference

17 December 2017

T Henry

2

1 reference

17 December 2017

J Goldman

3

1 reference

17 December 2017

I Baumgartner

4

1 reference

17 December 2017

E van Belle

5

1 reference

17 December 2017

J Gerss

6

1 reference

17 December 2017

A T Hirsch

7

1 reference

17 December 2017

S Nikol

8

1 reference

17 December 2017

publication date

30 June 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

264-270

1 reference

17 December 2017

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Peripheral arterial disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Critical limb ischemia: definition and natural history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Screening for cancer and coronary risk factors through a nurse practitioner-staffed preventive health clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Relation of body mass index to cancer risk in 362,552 Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Retinal microvascularisation abnormalities and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: clinical trial methodology. Basel PAD Clinical Trial Methodology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Correlation of coronary with peripheral arterial stenosis. The POSCH Group

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.85

7 January 2021

Identifiers

DOI

10.1038/GT.2011.85

1 reference

17 December 2017

Dimensions Publication ID

1010358274

0 references

1 reference

17 December 2017